Abstract:Targeted combination nanomedicine can be employed as a potent approach for cancer treatment. However, the inadequacy of most preclinical tumor models for drug/nanotherapeutic screening has limited their clinical translation. As promising in vitro models, three-dimensional (3D)-printed microfluidic devices can be fabricated in a high-throughput cost-effective manner for various biomedical applications. In this study, using a 3D printed mold, a microwell-based breast tumor-on-a-chip was developed. A modified protocol was devised for the surface treatment of the resin-based 3D-printed template making it suitable for repeated long-term polydimethylsiloxane (PDMS) casting. The versatility of the chip was demonstrated through both biorelevant scaffold-free 3D tumor spheroid culture and nanomedicine screening. Representative of avascular tumor tissues, tumor spheroids were generated in this platform and exhibited tight structure with a size range of 300–500 μm, internal cellular layers, and in vivo pathophysiology conditions. A targeted drug delivery system of 5-fluorouracil, curcumin, and piperine co-loaded folate-conjugated human serum albumin nanoparticles (FA-5FU-CUR-PIP-HSA-NPs) was synthesized by the self-assembly method and both hydrophobic and hydrophilic drugs were encapsulated in the NPs. The transport mechanism and efficacy of the NPs were investigated on the tumor model tissue. Possessing proper physical, biological, and pharmaceutical drug combination, the targeted NPs formulation with the potential of cancer theranostics demonstrated enhanced internalization and accumulation into triple-negative MDA-MB-231 breast cancer microtissues upon both passive and active targeting. The increased penetration and uptake of the targeted NPs in tumor spheroids were translated into boosted anticancer activity. Compatible with the uptake and cytotoxicity test, higher cell apoptosis was observed for the targeted nanomedicine than for the non-targeted NPs. Together, the combination of microfluidics and nanomedicine approaches can benefit basic research related to human disease. Graphical abstract Download : Download high-res image (245KB) Download : Download full-size image

MSC-derived exosomes enhance the anticancer activity of drugs in 3D spheroid of breast cancer cells

A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy

Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3′-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer

Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy.

Enhanced Therapeutic Potential of Hybrid Exosomes Loaded with Paclitaxel for Cancer Therapy

Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy

Mesenchymal stem cells-derived exosomes: novel carriers for nanoparticle to combat cancer

The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells

Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device

Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy

Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy

Bone marrow mesenchymal stem cell-derived exosomes improve cancer drug delivery in human cell lines and a mouse osteosarcoma model

ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells

Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy

Enhanced anti-tumor efficacy of S3I-201 in breast cancer mouse model through Wharton jelly- exosome

Mimicking 3D breast tumor-stromal interactions to screen novel cancer therapeutics

Doxorubicin-loaded NK exosomes enable cytotoxicity against triple-negative breast cancer spheroids

Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer

Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer

Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel

Evaluation of a targeted drug delivery system on breast tumor spheroids on a chip